 Tel:+86-755-26890807

UPCOMING EVENTS: São Paulo, Hospitalar 2024:E-390-d

News Detail
Home / News / Company News / Goldsite COVID-19 SARS-CoV-2 Antigen Test Kit(ATK) on process in Thailand FDA

Goldsite COVID-19 SARS-CoV-2 Antigen Test Kit(ATK) on process in Thailand FDA

Author: Scarlett     Publish Time: 2021-09-16      Origin: Site


facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

Goldsite COVID-19 SARS-Cov-2 Nasal Antigen Test Kit (ATK) for self-test (ชุดตรวจสำหรับ Covid-19 ประเภทตรวจหาแอนติเจนด้วยตนเอง) is being processd by FDA in thailand. Good news comes in that after the evaluation Thailand health authority lab reach an expert consensus that the sensitivity and specificity of the kit are 100% and 96.67% respectively, matching with Goldsite' internal and other third-party conducted clinical report data of 100%, 97.17% respectively. Prof. Dr. Teerawat Hemajuta (Doctor Theerawat), Director of the Center for Emerging Health Sciences Faculty of Medicine Chulalongkorn University stated that a good Rapid ATK test must have 100% sensitivity. This is a substantial proof that Goldsite's Self test Rapid Antigen Test Kit (ATK) keeps showing its excellent and stable performance.

英文头图 640px

Main Features of Goldsite SARS-CoV-2 ATK for self-test

  • EASY. No special equipment and expertise needed.

  • Accurate. Clinical performance of sensitivity and specificity: 100%, 97.17%

  • RAPID. Only 12 mins waiting time.

  • Nasal, nasopharyngeal and oropharyngeal swabs acceptable

  • Good correlation with RT-PCR detection.

  • Room temperature storage


See Goldsite's latest trend on social media.

Goldsite Diagnostics Inc., founded in 1999, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents.

Quick Links

Product Links

Get in touch




Copyright © 1999- 2023 Goldsite Diagnostics Inc., All rights reserved.  Sitemap